- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 92,200 | 02.07.24 08:03:10 | -0,070 | -0,08% | 92,020 | 92,250 | 92,200 | 92,270 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 981,600 | 02.07.24 08:09:11 | +6,400 | +0,66% | 979,800 | 989,400 | 981,600 | 975,200 |
